<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>11</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Impact of HLA-E Polymorphisms in Graft-versus-Host Disease following HLA-E Matched Allogeneic Hematopoietic Stem Cell Transplantation</title>
    <FirstPage>15</FirstPage>
    <LastPage>21</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ehteramolsadat</FirstName>
        <LastName>Hosseini</LastName>
        <affiliation locale="en_US">Malignant Hematology and Stem Cell Transplantation Service, Alfred Hospital, Monash University, Melbourne, Australia</affiliation>
      </Author>
      <Author>
        <FirstName>Anthony</FirstName>
        <LastName>P. Schwarer</LastName>
        <affiliation locale="en_US">Malignant Hematology and Stem Cell Transplantation Service, Alfred Hospital, Monash University, Melbourne, Australia</affiliation>
      </Author>
      <Author>
        <FirstName>Mehran</FirstName>
        <LastName>Ghasemzadeh</LastName>
        <affiliation locale="en_US">Australian Centre for Blood Diseases, Monash University, Melbourne, Australia</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The&#xA0; non-classical MHC&#xA0; class-I mainly involves in the&#xA0; regulation of&#xA0; innate&#xA0; immune responses where HLA-E&#xA0; plays a significant role in the cell identification by natural killer cells. HLA-E is a main regulatory ligand for natural killer cells and given the importance of these effector cells in hematopoietic stem cell transplantation, we investigated the effect of HLA-E polymorphisms on post-hematopoietic stem cell transplantation outcomes.
The study group included 56 donor-patient pairs with underlying malignant hematological disorders undergoing HLA-E&#xA0; matched allogeneic hematopoietic stem cell transplantation. They were genotyped for HLA-E locus using a sequence specific primer-polymerase chain reaction. The&#xA0; median follow-up was 20.6 months&#xA0; (range 0.2-114.8) and&#xA0; the&#xA0; parameters assessed were acute and chronic graft-versus-host disease and overall survival.
We showed a lower frequency of acute graft-versus-host disease (grade II or more; p=0.02)and chronic graft-versus-host disease (extensive; p=0.04) in the patients with HLA- E*0103/0103 genotype compared to other genotypes of HLA-E. There was also an association between HLA-E*0103/0103 and improved overall survival (p=0.001).
Conclusively, our&#xA0; results&#xA0; suggest a&#xA0; protective&#xA0; role&#xA0; for&#xA0; HLA-E*0103/0103&#xA0; genotypeagainst acute graft-versus-host disease (grade II or more) and chronic graft-versus-host disease (extensive) as well as an association between this genotype and a better overall survival after HLA-E matched allogeneic hematopoietic stem cell transplantation.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/326</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/326/326</pdf_url>
  </Article>
</Articles>
